Back to Journals » Drug Design, Development and Therapy » Volume 15

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects

Total article views   HTML views PDF downloads Totals
5,157 Dovepress* 4,601+ 400 5,001
PubMed Central* 556 164 720
Totals 5,157 564 5,721
*Since 6 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar